Assessment of Energetic Resonance by Cutaneous Stimulation on Withdrawal Alcohol Symptoms.

Hospices Civils de Lyon43 enrolled

Overview

The purpose of RESC study is to assess the efficacy of Energetic Resonance by Cutaneous Stimulation on alcohol withdrawal symptoms measured by CUSHMAN score and in a second time to measure the benzodiazepine amount prescribed during the withdrawal time.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

SUPPORTIVE_CARE

Masking

NONE

Enrollment

Conditions

Alcohol Withdrawal Syndrome

Interventions

Energetic Resonance by Cutaneous StimulationOTHER

Energetic Resonance by Cutaneous Stimulation (RESC) is a non-invasive method based on energetic Chinese medicine principles and digital contact. RESC is characterized by echo phenomena between two stimulation points.

Eligibility

Sex: ALLMin age: 18 YearsMax age: 80 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Men and women between 18 and 80 years, * Patient with alcohol addiction, * Patient needing alcohol withdrawal in a hospital. * Patient with social Security, * Patient with inform consent signed. Exclusion Criteria: * Pregnant women * Minor. * Major with guardianship. * People without sufficient information because of troubles of cognitive functions, or without sufficient knowledge of French language.

Locations (1)

Hôpital croix rousse

Lyon, France

Outcomes

Primary Outcomes

Cushman Score measure after Energetic Resonance by Cutaneous Stimulation

CUSHMAN score is represented by a scale with 7 variables collecting physiological modifications or behavioural manifestations related to adrenergic answer, neurovegetative signs, confusion, nervousness, perceptive or hallucinatory phenomena.

Time frame: daily during one week

Secondary Outcomes

Anxiety depression scale

Time frame: pre-screening, day 3 and day 7

prescribed benzodiazepine amount

Time frame: day 0 to day 7

Analogic Visual Scale

Time frame: before and after each Energetic Resonance by Cutaneous Stimulationsession at day 2, day 4 and day 6.

Quality of life scale

Time frame: day 0

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.